http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006046847-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4aa6a6446ea33884587a381410dc26e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6bfc39ded49ab793928c5e0343866ad9
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722
filingDate 2005-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b9ffc5d142114b37e0b62fb448aca74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caae4726351af40a4770bcfb67b1004d
publicationDate 2006-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006046847-A1
titleOfInvention Composition for the treatment of obesity and hyperlipidaemia
abstract The invention relates to the pharmaceutical industry and, more specifically, the industry involved in the manufacture of pharmaceutical products used to reduce weight and to treat hyperlipidaemia. The invention is advantageous over similar existing compositions in that it eliminates the collateral effects normally caused by ingestion of a lipase inhibitor. According to the invention, both the lipase inhibitor component and the fat-trapper are optimised, using a suitable composition for, and very small quantities of each of the components. The invention relates to a composition for the treatment of obesity and hyperlipidaemia, which is characterised in that it combines a lipase inhibitor and a fat-trapper compound.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2427823-A
priorityDate 2004-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5411956-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6030953-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406592
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394773

Total number of triples: 24.